Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Treatment
Elite Pharmaceuticals launches generic Vyvanse (Lisdexamfetamine Dimesylate) for ADHD, targeting a $4.3 billion market. This generic version is available in multiple strengths and marketed under Elite Laboratories, Inc.
Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Treatment Read More »